Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Skórzewo
Clinical trial register · Poland

Clinical Trials in Skórzewo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2709 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2709
Studies in scope
all four open statuses
1380
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Warsaw 1318 Krakow 881 Poznan 697 Gdansk 663 Lodz 618
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Celgene5 Hoffmann-La Roche3 Merck Sharp & Dohme LLC3 AstraZeneca3 Loxo Oncology, Inc.2 Genmab2 Eli Lilly and Company2 Poznan University of Medical Sciences2 Karyopharm Therapeutics Inc2 Incyte Corporation2 Epizyme, Inc.1 Shanghai Junshi Bioscience Co., Ltd.1 Heidelberg Pharma AG1 Bristol-Myers Squibb1 Geron Corporation1 LimmaTech Biologics AG1 Pierre Fabre Medicament1 ImmunoVaccine Technologies, Inc. (IMV Inc.)1 AbbVie1 Vividion Therapeutics, Inc.1 Madrigal Pharmaceuticals, Inc.1 AFT Pharmaceuticals, Ltd.1 Immunocore Ltd1 Pfizer1 Ono Pharmaceutical Co., Ltd.1 Show all 29
Site location
Warsaw1318 Krakow881 Poznan697 Gdansk663 Lodz618 Wroclaw526 Bydgoszcz525 Lublin525 Katowice510 Bialystok388 Olsztyn190 Rzeszów183 Szczecin183 Gdynia167 Gliwice121 Kielce117 Torun111 Opole106 Koszalin84 Siedlce81 Zabrze69 Elblag67 Otwock56 Przemyśl55 Chorzów53 Show all 264
All 264 locations
Target enrolment
to

Trials with a site in Skórzewo

45 of 2709 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Not yet open
Poznan University of Medical Sciences
Not applicable
260
Skórzewo, Poznan
2026-12-01
Not yet open
AFT Pharmaceuticals, Ltd.
Phase 3
1,366
Skórzewo
2026-12
Recruiting
Faron Pharmaceuticals Ltd
Phase 2
90
Katowice, Skórzewo, Warsaw
2026-10
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Skórzewo, Krakow, Wroclaw, Otwock, Siedlce, Warsaw, Opole, Przemyśl
2026-09-11
Recruiting
AstraZeneca
Phase 3
915
Gdansk, Koszalin, Poznan, Siedlce, Skórzewo, Wroclaw
2026-07-16
Recruiting
Poznan University of Medical Sciences
Not applicable
100
Skórzewo
2026-06-01
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
250
Skórzewo, Torun, Wroclaw
2026-05-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Skórzewo, Krakow, Siedlce, Warsaw, Gliwice
2026-04-09
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bydgoszcz, Koszalin, Krakow, Skórzewo, Sosnowiec, Warsaw, Wrocaw
2025-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Skórzewo, Bydgoszcz, Krakow, Siedlce, Warsaw, Przemyśl, Koszalin
2025-11-26
Recruiting
Eli Lilly and Company
Phase 3
1,000
Bydgoszcz, Skórzewo, Szczecin, Warsaw, Wroclaw
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Skórzewo, Biała Podlaska, Warsaw, Opole, Lodz
2025-09-11
Recruiting
Celgene
Phase 3
400
Skórzewo, Krakow, Warsaw, Gdynia, Lodz
2025-07-28
Recruiting
Merck Sharp & Dohme LLC
Phase 2
594
Skórzewo, Krakow, Nowy Sącz, Wałbrzych, Warsaw, Gdansk, Katowice
2025-04-11
Recruiting
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06980116Relapsed or Refractory B-cell Malignancies, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL)
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Phase 1
85
Krakow, Lodz, Lublin, Skórzewo
2025-03-31
Active, closed
AbbVie
Phase 2
150
Skórzewo, Warsaw
2025-01-20
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Bydgoszcz, Katowice, Krakow, Skórzewo, Wroclaw
2025-01-03
Active, closed
Hoffmann-La Roche
Phase 2
62
Bydgoszcz, Skórzewo
2024-12-09
Active, closed
Celgene
Phase 2
95
Skórzewo, Bydgoszcz, Warsaw
2024-08-30
Active, closed
Celgene
Phase 3
850
Skórzewo, Bydgoszcz, Krakow, Lublin, Warsaw, Katowice
2024-06-19
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Lublin, Skórzewo, Torun
2024-04-22
Active, closed
LimmaTech Biologics AG
Phase 1/2
251
Skórzewo, Bydgoszcz, Katowice, Lublin, Warsaw
2023-12-06
Active, closed
Comparative Efficacy, Safety, PK, and Immunogenicity Study
NCT05853354Osteoporosis, Postmenopausal
DrugDenosumab
Luye Pharma Group Ltd.
Phase 3
392
Skórzewo, Katowice, Częstochowa, Gdansk, Gdynia, Jelenia Góra, Krakow, Lodz
2023-04-05
Active, closed
Genmab
Phase 3
900
Piła, Skórzewo, Słupsk, Olsztyn, Kielce
2023-02-08
Active, closed
Incyte Corporation
Phase 3
82
Bydgoszcz, Gdansk, Gdynia, Lublin, Olsztyn, Skórzewo, Warsaw, Wroclaw
2022-12-23
Recruiting
Celgene
Phase 3
810
Skórzewo, Torun, Krakow, Warsaw, Słupsk, Katowice
2022-09-20
Active, closed
Genmab
Phase 3
549
Piła, Skórzewo, Krakow, Gdynia, Kielce
2022-09-20
Active, closed
AstraZeneca
Phase 3
594
Gdansk, Krakow, Poznan, Skórzewo
2022-09-15
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Biała Podlaska, Bydgoszcz, Gdansk, Katowice, Krakow, Lublin, Skórzewo, Wroclaw
2022-07-22
Active, closed
Incyte Corporation
Phase 1/2
53
Skórzewo, Krakow, Wroclaw, Warsaw, Opole, Gdynia, Lodz, Olsztyn
2022-07-19
Active, closed
Pierre Fabre Medicament
Phase 3
815
Gliwice, Konin, Krakow, Poznan, Skórzewo, Warsaw, Wroclaw
2022-05-02
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL)
DrugBexobrutideg
Nurix Therapeutics, Inc.
Phase 1
572
Skórzewo, Krakow, Wroclaw, Warsaw, Katowice, Lublin
2022-04-13
Active, closed
Pfizer
Phase 3
854
Skórzewo, Katowice, Gdansk, Poznan, Warsaw, Wroclaw
2022-03-25
Recruiting
Heidelberg Pharma AG
Phase 1/2
78
Katowice, Krakow, Lodz, Opole, Skórzewo, Torun
2022-02-07
Active, closed
Celgene
Phase 1
224
Skórzewo, Gdansk, Krakow, Słomniki, Warsaw, Wroclaw
2021-09-15
Active, closed
AstraZeneca
Phase 3
712
Gdansk, Nowa Sól, Skórzewo, Warsaw
2021-08-05
Recruiting
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
102
Gdynia, Legnica, Olsztyn, Skórzewo, Warsaw
2021-06-18
Active, closed
Geron Corporation
Phase 3
327
Piła, Skórzewo, Katowice, Biała Podlaska
2021-04-12
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Skórzewo, Torun, Wroclaw, Lublin, Brzozów, Gdansk, Katowice, Wałbrzych
2021-03-11
Active, closed
Hoffmann-La Roche
Phase 3
210
Bydgoszcz, Gdansk, Lublin, Skórzewo, Warsaw
2020-10-08
Active, closed
Hoffmann-La Roche
Phase 3
190
Bydgoszcz, Gda?sk, Lublin, Skórzewo, Warsaw
2020-09-30
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Gdansk, Koszalin, Krakow, Mysłowice, Poznan, Skórzewo, Warsaw
2020-06-29
Active, closed
Epizyme, Inc.
Phase 3
599
Skórzewo, Warsaw, Katowice, Krakow, Torun, Wroclaw
2020-06-11
Active, closed
Immunocore Ltd
Phase 1/2
410
Skórzewo, Warsaw
2020-02-25
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Częstochowa, Gdansk, Gdynia, Katowice, Lodz, Poznan, Skórzewo, Warsaw
2019-03-28
Rows per page Showing 1–45 of 45
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-poland/city/sk-rzewo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,709 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 45 of those studies with a site in Skórzewo.

How many clinical trials are recruiting in Skórzewo?

20 of the 45 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 23 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Skórzewo), 45 studies
PhaseStudiesRecruitingShare
Phase 326957.8%
Phase 29620%
Phase 1/2418.9%
Phase 1326.7%
Not applicable214.4%
Phase 2/3112.2%

Most active sponsors

Lead sponsors with the most studies (Skórzewo)
Lead sponsorStudiesRecruiting
Celgene52
AstraZeneca31
Hoffmann-La Roche30
Merck Sharp & Dohme LLC33
Eli Lilly and Company22
Genmab20
Incyte Corporation20
Karyopharm Therapeutics Inc21
Loxo Oncology, Inc.22
Poznan University of Medical Sciences21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.